Literature DB >> 12915002

Signal detection behavior in humans and rats: a comparison with matched tasks.

Philip J. Bushnell1, Vernon A. Benignus, Martin W. Case.   

Abstract

Animal models of human cognitive processes are essential for studying the neurobiological mechanisms of these processes and for developing therapies for intoxication and neurodegenerative diseases. A discrete-trial signal detection task was developed for assessing sustained attention in rats; a previous study showed that rats perform as predicted from the human sustained attention literature. In this study, we measured the behavior of humans in a task formally homologous to the task for rats, varying two of the three parameters previously shown to affect performance in rats. Signal quality was manipulated by varying the increment in the intensity of a lamp. Trial rate was varied among values of 4, 7, and 10 trials/min. Accuracy of signal detection was quantified by the proportion of correct detections of the signal (P(hit)) and the proportion of false alarms (P(fa), i.e. incorrect responses on non-signal trials). As with rats, P(hit) in humans increased with increasing signal intensity whereas P(fa) did not. Like rats, humans were sensitive to the trial rate, though the change in behavior depended on the sex of the subject. These data show that visual signal detection behavior in rats and humans is controlled similarly by two important parameters, and suggest that this task assesses similar processes of sustained attention in the two species.

Entities:  

Year:  2003        PMID: 12915002     DOI: 10.1016/s0376-6357(03)00146-3

Source DB:  PubMed          Journal:  Behav Processes        ISSN: 0376-6357            Impact factor:   1.777


  12 in total

1.  Can too strong female choice deteriorate male ornamentation?

Authors:  Lesley J Morrell; Hanna Kokko
Journal:  Proc Biol Sci       Date:  2004-08-07       Impact factor: 5.349

2.  Prestimulus frontal-parietal coherence predicts auditory detection performance in rats.

Authors:  Linnea Herzog; Kia Salehi; Kaitlin S Bohon; Michael C Wiest
Journal:  J Neurophysiol       Date:  2014-02-26       Impact factor: 2.714

Review 3.  Attention-modulating effects of cognitive enhancers.

Authors:  Edward D Levin; Philip J Bushnell; Amir H Rezvani
Journal:  Pharmacol Biochem Behav       Date:  2011-02-18       Impact factor: 3.533

4.  Rats and humans paying attention: cross-species task development for translational research.

Authors:  Elise Demeter; Martin Sarter; Cindy Lustig
Journal:  Neuropsychology       Date:  2008-11       Impact factor: 3.295

5.  Systemic and intrabasalis administration of the orexin-1 receptor antagonist, SB-334867, disrupts attentional performance in rats.

Authors:  Karen E Boschen; Jim R Fadel; Joshua A Burk
Journal:  Psychopharmacology (Berl)       Date:  2009-07-03       Impact factor: 4.530

Review 6.  A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia.

Authors:  Martin Sarter; Vicente Martinez; Rouba Kozak
Journal:  Psychopharmacology (Berl)       Date:  2008-07-10       Impact factor: 4.530

7.  Repeated visual distracter exposure enhances new discrimination learning and sustained attention task performance in rats.

Authors:  Adam H Hirsh; Joshua A Burk
Journal:  Behav Processes       Date:  2012-11-19       Impact factor: 1.777

8.  Orexin A-induced enhancement of attentional processing in rats: role of basal forebrain neurons.

Authors:  Kristin N Zajo; Jim R Fadel; Joshua A Burk
Journal:  Psychopharmacology (Berl)       Date:  2015-11-04       Impact factor: 4.530

Review 9.  The 5 choice continuous performance test (5C-CPT): A novel tool to assess cognitive control across species.

Authors:  Savita G Bhakta; Jared W Young
Journal:  J Neurosci Methods       Date:  2017-07-25       Impact factor: 2.390

10.  Neurophysiological Characterization of Attentional Performance Dysfunction in Schizophrenia Patients in a Reverse-Translated Task.

Authors:  Jared W Young; Andrew W Bismark; Yinming Sun; Wendy Zhang; Meghan McIlwain; Ibrahim Grootendorst; Gregory A Light
Journal:  Neuropsychopharmacology       Date:  2016-12-05       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.